Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic
Authors:
- Iulia-Monica GrozaIGIulia-Monica Groza
- Cornelia BraicuCornelia Braicu
- Ancuta JurjAncuta Jurj
- Oana ZanoagaOZOana Zanoaga
- Raduly LajosRaduly Lajos
- Paul ChiroiPaul Chiroi
- Roxana CojocneanuRCRoxana Cojocneanu
- Diana PaunDPDiana Paun
- Alexandru IrimieAIAlexandru Irimie
- Schuyler S. KorbanSKSchuyler S. Korban
- Patriciu Achimas-CadariuPAPatriciu Achimas-Cadariu
- Ioana Berindan-NeagoeIoana Berindan-Neagoe
Open Access
Abstract
Breast cancer is one of the most common oncological diseases in women, as its incidence is rapidly growing, rendering it unpredictable and causing more harm than ever before on an annual basis. Alterations of coding and noncoding genes are related to tumorigenesis and breast cancer progression. In this study, several key genes associated with epithelial-to-mesenchymal transition (EMT) and cancer stem cell (CSC) features were identified. EMT and CSCs are two key mechanisms responsible for self-renewal, differentiation, and self-protection, thus contributing to drug resistance. Therefore, understanding of the relationship between these processes may identify a therapeutic vulnerability that can be further exploited in clinical practice, and evaluate its correlation with overall survival rate. To determine expression levels of altered coding and noncoding genes, The Cancer Omics Atlas (TCOA) are used, and these data are overlapped with a list of CSCs and EMT-specific genes downloaded from NCBI. As a result, it is observed that CSCs are reciprocally related to EMT, thus identifying common signatures that allow for predicting the overall survival for breast cancer genes (BRCA). In fact, common CSCs and EMT signatures, represented by ALDH1A1, SFRP1, miR-139, miR-21, and miR-200c, are deemed useful as prognostic biomarkers for BRCA. Therefore, by mapping changes in gene expression across CSCs and EMT, suggesting a cross-talk between these two processes, we have been able to identify either the most common or specific genes or miRNA markers associated with overall survival rate. Thus, a better understanding of these mechanisms will lead to more effective treatment options.Keywords
This publication has 66 references indexed in Scilit:
- miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1Current Medical Science, 2014
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstressFree Radical Biology and Medicine, 2013
- The Implications of Cancer Stem Cells for Cancer TherapyInternational Journal of Molecular Sciences, 2012
- Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by Blimp-1–Dependent Repression of BMP-5Cancer Research, 2012
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtypeJournal of Clinical Pathology, 2011
- Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transitionBreast Cancer Research, 2011
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAsNature Cell Biology, 2011
- PANTHER Pathway: An Ontology-Based Pathway Database Coupled with Data Analysis Tools2009
- CXC chemokines located in the 4q21 region are up-regulated in breast cancerEndocrine-Related Cancer, 2007
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002